Resource Pack: Cost-Effectiveness of Screening and Treatment for Hypertension
2023
Hypertension is a relevant example for teaching clinical decision making, diagnostic test performance, positivity criterion, and cost-effectiveness analysis. This resource pack provides examples of decision analyses and cost-effectiveness analyses for the management and treatment of hypertension, with a predominant focus on the U.S. Analyses are included that predate the 2017 American College of Cardiology/American Heart Association Clinical Practice Guidelines, along with more recent examples that followed release of the guidelines. Resources are also included that provide an overview of empiric data underlying the 2017 guidelines and that review the main differences between the 2014 and 2017 guidelines.
Newer analyses include cost-effectiveness analyses evaluating strategies for clinic, home, or ambulatory blood pressure measurement, pharmacist prescribing for managing hypertension, screening and treatment of masked hypertension, and intensive vs. standard blood pressure control among older patients.
Click here to download a PDF document of this complete pack
Source:
Resource Pack: Cost-Effectiveness of Screening and Treatment for Hypertension. Center for Health Decision Science, Harvard T.H. Chan School of Public Health 2023. https://repository.chds.hsph.harvard.edu/repository/collection/resource-pack-new-blood-pressure-guidelines-in-us